FOXP3-mediated inhibition of Akt inhibits Glut1 (Glucose transporter 1) expression in human T regulatory cells

Journal of Leukocyte Biology

Volumn 97, Issue 2, 2015, Pages 279-283

  Basu, Samik ^a   Hubbard, Britany ^a   Shevach, Ethan M ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

Autoimmunity; Lymphocyte; Metabolism; Signal transduction

Indexed keywords

CD4 ANTIGEN; GLUCOSE; GLUCOSE TRANSPORTER 1; INTERLEUKIN 2; INTERLEUKIN 7 RECEPTOR; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN KINASE B; TRANSCRIPTION FACTOR FOXP3; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, HUMAN; LYMPHOCYTE ANTIGEN RECEPTOR; SLC2A1 PROTEIN, HUMAN;

ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CELL MEMBRANE; CELL SURFACE; CONTROLLED STUDY; CYTOKINE PRODUCTION; GENE EXPRESSION; GLUCOSE METABOLISM; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DEPHOSPHORYLATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; REGULATORY T LYMPHOCYTE; SIGNAL TRANSDUCTION; UPREGULATION; CLINICAL TRIAL; ENZYME ACTIVATION; FEMALE; IMMUNOLOGY; MALE;

CELL MEMBRANE; ENZYME ACTIVATION; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; GLUCOSE TRANSPORTER TYPE 1; HUMANS; MALE; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTORS, ANTIGEN, T-CELL; T-LYMPHOCYTES, REGULATORY; UP-REGULATION;

EID: 84922375253     PISSN: 07415400     EISSN: 19383673     Source Type: Journal    
DOI: 10.1189/jlb.2AB0514-273RR     Document Type: Article

References (23)

1. Smith-Garvin, J. E., Koretzky, G. A., Jordan, M. S. (2009) T cell activation. Annu. Rev. Immunol. 27, 591–619.
2. Fox, C. J., Hammerman, P. S., Thompson, C. B. (2005) Fuel feeds function: energy metabolism and the T-cell response. Nat. Rev. Immunol. 5, 844–852.
3. Crellin, N. K., Garcia, R. V., Levings, M. K. (2007) Altered activation of AKT is required for the suppressive function of human CD4+CD25+ T regulatory cells. Blood 109, 2014–2022.
4. Crellin, N. K., Garcia, R. V., Levings, M. K. (2007) Flow cytometry-based methods for studying signaling in human CD4+CD25+FOXP3+ T regulatory cells. J. Immunol. Methods 324, 92–104.
5. Patterson, S. J., Han, J. M., Garcia, R., Assi, K., Gao, T., O’Neill, A., Newton, A. C., Levings, M. K. (2011) Cutting edge: PHLPP regulates the development, function, and molecular signaling pathways of regulatory T cells. J. Immunol. 186, 5533–5537.
6. Sauer, S., Bruno, L., Hertweck, A., Finlay, D., Leleu, M., Spivakov, M., Knight, Z. A., Cobb, B. S., Cantrell, D., O’Connor, E., Shokat, K. M., Fisher, A. G., Merkenschlager, M. (2008) T cell receptor signaling controls Foxp3 expression via PI3K, Akt, and mTOR. Proc. Natl. Acad. Sci. USA 105, 7797–7802.
7. Bensinger, S. J., Walsh, P. T., Zhang, J., Carroll, M., Parsons, R., Rathmell, J. C., Thompson, C. B., Burchill, M. A., Farrar, M. A., Turka, L. A. (2004) Distinct IL-2 receptor signaling pattern in CD4+CD25+ regulatory T cells. J. Immunol. 172, 5287–5296.
8. Walsh, P. T., Buckler, J. L., Zhang, J., Gelman, A. E., Dalton, N. M., Taylor, D. K., Bensinger, S. J., Hancock, W. W., Turka, L. A. (2006) PTEN inhibits IL-2 receptor-mediated expansion of CD4+ CD25+ Tregs. J. Clin. Invest. 116, 2521–2531.
9. Frauwirth, K. A., Riley, J. L., Harris, M. H., Parry, R. V., Rathmell, J. C., Plas, D. R., Elstrom, R. L., June, C. H., Thompson, C. B. (2002) The CD28 signaling pathway regulates glucose metabolism. Immunity 16, 769–777.
10. Jacobs, S. R., Herman, C. E., Maciver, N. J., Wofford, J. A., Wieman, H. L., Hammen, J. J., Rathmell, J. C. (2008) Glucose uptake is limiting in T cell activation and requires CD28-mediated Akt-dependent and independent pathways. J. Immunol. 180, 4476–4486.
11. Michalek, R. D., Gerriets, V. A., Jacobs, S. R., Macintyre, A. N., MacIver, N. J., Mason, E. F., Sullivan, S. A., Nichols, A. G., Rathmell, J. C. (2011) Cutting edge: distinct glycolytic and lipid oxidative metabolic programs are essential for effector and regulatory CD4+ T cell subsets. J. Immunol. 186, 3299–3303.
12. Macintyre, A. N., Gerriets, V. A., Nichols, A. G., Michalek, R. D., Rudolph, M. C., Deoliveira, D., Anderson, S. M., Abel, E. D., Chen, B. J., Hale, L. P., Rathmell, J. C. (2014) The glucose transporter Glut1 is selectively essential for CD4 T cell activation and effector function. Cell Metab. 20, 61–72.
13. Shevach, E. M., Thornton, A. M. (2014) tTregs, pTregs, and iTregs: similarities and differences. Immunol. Rev. 259, 88–102.
14. Jo, H., Mondal, S., Tan, D., Nagata, E., Takizawa, S., Sharma, A. K., Hou, Q., Shanmugasundaram, K., Prasad, A., Tung, J. K., Tejeda, A. O., Man, H., Rigby, A. C., Luo, H. R. (2012) Small molecule-induced cytosolic activation of protein kinase Akt rescues ischemia-elicited neuronal death. Proc. Natl. Acad. Sci. USA 109, 10581–10586.
15. Tran, D. Q., Andersson, J., Wang, R., Ramsey, H., Unutmaz, D., Shevach, E. M. (2009) GARP (LRRC32) is essential for the surface expression of latent TGF-beta on platelets and activated FOXP3+ regulatory T cells. Proc. Natl. Acad. Sci. USA 106, 13445–13450.
16. Basu, S., Golovina, T., Mikheeva, T., June, C. H., Riley, J. L. (2008) Cutting edge: Foxp3-mediated induction of pim 2 allows human T regulatory cells to preferentially expand in rapamycin. J. Immunol. 180, 5794–5798.
17. Chemnitz, J. M., Lanfranco, A. R., Braunstein, I., Riley, J. L. (2006) B and T lymphocyte attenuator-mediated signal transduction provides a potent inhibitory signal to primary human CD4 T cells that can be initiated by multiple phosphotyrosine motifs. J. Immunol. 176, 6603–6614.
18. Smith, P. M., Howitt, M. R., Panikov, N., Michaud, M., Gallini, C. A., Bohlooly Y M., Glickman, J. N., Garrett, W. S. (2013) The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis. Science 341, 569–573.
19. Sugimoto, N., Oida, T., Hirota, K., Nakamura, K., Nomura, T., Uchiyama, T., Sakaguchi, S. (2006) Foxp3-dependent and-independent molecules specific for CD25+CD4+ natural regulatory T cells revealed by DNA microarray analysis. Int. Immunol. 18, 1197–1209.
20. Zheng, Y., Josefowicz, S. Z., Kas, A., Chu, T. T., Gavin, M. A., Rudensky, A. Y. (2007) Genome-wide analysis of Foxp3 target genes in developing and mature regulatory T cells. Nature 445, 936–940.
21. Ziegler, S. F. (2006) FOXP3: of mice and men. Annu. Rev. Immunol. 24, 209–226.
22. Francisco, L. M., Sage, P. T., Sharpe, A. H. (2010) The PD-1 pathway in tolerance and autoimmunity. Immunol. Rev. 236, 219–242.
23. Sadlon, T. J., Wilkinson, B. G., Pederson, S., Brown, C. Y., Bresatz, S., Gargett, T., Melville, E. L., Peng, K., D’Andrea, R. J., Glonek, G. G., Goodall, G. J., Zola, H., Shannon, M. F., Barry, S. C. (2010) Genome-wide identification of human FOXP3 target genes in natural regulatory T cells. J. Immunol. 185, 1071–1081.